A detailed history of M&G PLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, M&G PLC holds 4,622 shares of EW stock, worth $316,653. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,622
Previous 8,775 47.33%
Holding current value
$316,653
Previous $579 Million 40.94%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$64.54 - $75.92 $268,034 - $315,295
-4,153 Reduced 47.33%
4,622 $342 Million
Q3 2024

Oct 31, 2024

SELL
$59.7 - $93.78 $32,238 - $50,641
-540 Reduced 5.8%
8,775 $579 Million
Q2 2024

Jul 16, 2024

BUY
$84.3 - $94.31 $36,333 - $40,647
431 Added 4.85%
9,315 $857 Million
Q1 2024

May 10, 2024

BUY
$72.54 - $95.56 $644,445 - $848,955
8,884 New
8,884 $853 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $42.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track M&G PLC Portfolio

Follow M&G PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G PLC, based on Form 13F filings with the SEC.

News

Stay updated on M&G PLC with notifications on news.